SelectScience
Join Free
NewsDrug discovery > Lead Discovery

Copley Scientific to Present Albuterol Products at Respiratory Drug Delivery 2018

Copley Scientific Ltd
19 Apr 2018
Han Yin
Administrator / Office Personnel

Product news

Generic developers looking to apply the recently proposed draft US Pharmacopoeia (USP) monograph for Albuterol Inhalation Aerosols will find relevant new testing equipment at the Copley Scientific stand at Respiratory Drug Delivery 2018 (April 22nd to 26th, Tucson, Arizona). The new TPK™ 2100 Critical Flow Controller, a highly automated unit for reproducible, cost-efficient dry powder inhaler (DPI) testing, will also make its US debut. Copley Scientific is proud to be sponsoring this key event in the inhalation calendar, and experts from the company will be in attendance throughout to discuss any aspect of inhaler testing.

Albuterol, a popular generic target also known as salbutamol, is a β2 agonist (bronchodilator) used globally for the treatment of asthma and chronic obstructive pulmonary disease. Product specific FDA guidance and USP monographs directly support the development of important generic drugs, but frequently call for the application of unique test equipment, associated with the original product development.

Discover the latest news from drug manufacturing industry, join our Drug Manufacture Community >>

The proposed USP monograph for Albuterol Inhalation Aerosols, which was released in January 2018, specifies a non-standard sampling apparatus for delivered dose uniformity (DDU) testing, and an alternative to the standard USP induction port for aerodynamic particle size distribution (APSD) measurement using an Andersen Cascade Impactor (ACI). Copley Scientific will use the conference to launch new equipment to directly meet these requirements along with an accessory that allows the use of existing mouthpiece adapters, to simplify interfacing the inhaler with the induction port.

Copley Critical Flow Controllers are an internationally recognized standard for DPI testing that enable the set-up, control and documentation of all the parameters associated with both DDU and APSD measurement. The third generation TPK™ 2100 breaks new ground in terms of ease of use, improved reproducibility, and enhanced data output and recording. It exemplifies a suite of innovative designs that Copley has introduced over the last year to minimize the potential impact of user variability in inhaler testing and boost analytical productivity.

Receive the latest drug manufacturing news straight to your inbox. Become a free member today.

Links

Copley Scientific LtdCompany website

Tags

Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Drug DeliveryDrug Delivery refers to dosage form, route of administration, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via the biopharmaceutical or small molecule drug's formulation, but it may also involve medical devices or drug-device combination products. Considerations include instrumentation, software and services. RegulatoryPharmaceutical regulations impact on all areas of drug development, manufacture and control and supply. Services are provided from the early stages of drug development and clinical trials through to dossier submission, approval and marketing. Regulatory also includes submission of analytical studies from the pharmaceutical product and safety. Drug DosageDosage is the size or frequency of the administration of a drug. Determination of the dosage of a drug is critical in pharmaceutical development to ensure the optimum balance between efficacy and toxicity.Drug TestingIt is essential to test the efficacy and toxicity of drugs at every stage of their development to ensure that a pharmaceutical product is fit for purpose and safe for use before reaching the stage of mass production and distribution.PharmaceuticalsPharmaceuticals are medicinal drugs used in healthcare to diagnose, prevent, cure and treat illnesses. Pharmaceuticals that are excreted after use appear in wastewater and can have detrimental effects on the environment.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.

Related articles